ArticleBMC plant biology2025
Coix lacryma-jobi root extract exhibits self-toxicity, with butyl palmitate being the primary toxic substance.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Coix lacryma-jobi growth is often inhibited by continuous cropping due to autotoxic effects. The autotoxic effects and decomposition of aqueous extracts from different parts of C. lacryma-jobi plants and impact of their decomposed matter are unclear. The present study tested aqueous extracts from shoots, roots, and decomposed residues at four concentrations to assess their autotoxic properties. The extracts and decomposition products inhibited seed germination and seedling growth in a concentration-dependent manner. At concentrations of ≥ 0.1 g mL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.